Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
New to Comunitee?

or Sign Up with Email


>> VACCINE Latest News

JAN 25, 2013 - Yahoo! News

A Must Read - Share

Pfizer Prevnar vaccine wins approval for ages 6-17

(Reuters) - Pfizer Inc on Friday said U.S. regulators had approved wider use of its Prevnar 13 vaccine to prevent infections with pneumococcal bacteria, for children and adolescents aged 6 years to 17 years. The product was already approved in the United States to prevent infections among children aged 6 weeks through 5 years. It is also approved for adults aged 50 and older. The vaccine protects against infection with 13 strains of the Streptococcus pneumoniae bacterium. The bacterium can cause pneumonia, ear infections and other problems. Prevnar 13 has annual sales of about $3. ...

Tags: Pfizer Prevnar vaccine wins approval for ages 6-17,  Vaccine Latest News